Randomised Controlled Trial of Intravitreal Triamcinolone in Patients with Diabetic Macular Oedema Refractory to Laser Treatment
| ISRCTN | ISRCTN90614292 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN90614292 |
| Protocol serial number | N0192133909 |
| Sponsor | Department of Health |
| Funder | Queen's Medical Centre University Hospital NHS Trust (UK) |
- Submission date
- 30/09/2004
- Registration date
- 30/09/2004
- Last edited
- 13/04/2011
- Recruitment status
- Stopped
- Overall study status
- Stopped
- Condition category
- Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Mr S A Vernon
Scientific
Scientific
B Floor
The Eye & ENT Unit
University Hospital
Nottingham
NG7 2UH
United Kingdom
| Phone | +44 (0)115 924 9924 |
|---|---|
| stephen.vernon@nuh.nhs.uk |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | |
| Study objectives | Does principal intravitreal injection of triamcinolone help in treating diabetic patients with clinically significant macular oedema that is refractory to the conventional focal or grid laser photocoagulation? |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Eye Diseases: Diabetic macular oedema |
| Intervention | 1. Intravitreal injection of tiamcinolone 2. Placebo As of March 2008: trial abandoned due to poor recruitment. |
| Intervention type | Drug |
| Phase | Not Specified |
| Drug / device / biological / vaccine name(s) | Triamcinolone |
| Primary outcome measure(s) |
Pre-injection and then month 1, 3 and 6 |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 01/07/2006 |
| Reason abandoned (if study stopped) | Lack of staff/facilities/resources |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Key inclusion criteria | Not provided at time of registration |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 28/11/2003 |
| Date of final enrolment | 01/07/2006 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
B Floor
Nottingham
NG7 2UH
United Kingdom
NG7 2UH
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |